The Future of Psychedelic Access in Canada: PsyCan Releases White Paper Reviewing Regulatory Options for Psychedelics
03 oct. 2023 07h00 HE
|
Psychedelics Canada
PsyCan, the trade association for the for-profit psychedelic medicine industry, releases a white paper on how Health Canada can improve access to therapies
Sunstone Therapies Announces Expansion of Innovative Dyad Study
03 oct. 2023 07h00 HE
|
Sunstone Therapies
Sunstone Therapies Announces Expansion of Innovative Dyad Study Expansion of Phase 2 pilot trial to assess MDMA-assisted therapy for adjustment disorder in dyads of patients with cancer and a...
PharmAla Receives First Office Action for PharmAla-1 PCT Filing
25 sept. 2023 08h55 HE
|
PharmAla Biotech
PharmAla has recieved a positive First Office Action on its novel P-1 Molecule from the Patent Cooperation Treaty
Optimi Health Celebrates Encouraging Results from the MAPS Phase 3 MDMA-Assisted Therapy Clinical Trial
14 sept. 2023 14h59 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian psychedelics drug research and formulation company, is pleased...
Optimi Health Granted Amendment to Dealer's Licence by Health Canada to Supply Special Access Program
07 sept. 2023 07h30 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian psychedelics drug research and formulation company, proudly...
PharmAla Begins Trading on OTCQB
06 sept. 2023 08h55 HE
|
PharmAla Biotech
VANCOUVER, British Columbia, Sept. 06, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTCQB:PMBHF), a biotechnology company focused on the...
American Psychedelic Practitioners Association Retains The Daschle Group as Government Affairs Counsel
06 sept. 2023 08h00 HE
|
The American Psychedelic Practitioners Association
WASHINGTON, Sept. 06, 2023 (GLOBE NEWSWIRE) -- The American Psychedelic Practitioners Association (APPA), the leading organization focused on safely integrating psychedelics into the US healthcare...
Optimi Health Announces Second Tranche of CAD $1,000,000 Secured for Debt Financing
05 sept. 2023 07h30 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi Health” or the “Company”), a Canadian drug research and formulation...
MAPS Launches Online Video Sessions from Psychedelic Science 2023 with The Virtual Trip
30 août 2023 16h41 HE
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
PS2023: The Virtual Trip offers an opportunity to access a wide spectrum of sessions from Psychedelic Science 2023, the largest psychedelics conference in history.With a rolling release schedule,...
Cannabis Science Conference announces Mother Earth Wellness as host of the fall 2023 Canna Boot Camp
22 août 2023 14h34 HE
|
Cannabis Science Conference
CRANBURY, N.J., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Cannabis Science Conference (CSC), the premier cannabis science conference focusing on analytical science, medical cannabis, cultivation and...